Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Raymond James Cuts Impath to 'Underperform'


Raymond James downgraded Impath (IMPH) to underperform from market perform.

Analyst John Ransom says an auditing committee has started a review of Impath's historical finl results due to indications of irregularities in the valuation of receivables, and the GeneBank asset, both of which may have been overstated. Impath also announced the resignation of the vice president of finance, and the controller, suggesting a specter of some internal malfeasance.

Given Impath's already tenuous liquidity position, Ransom thinks deteriorating operating performance, along with accounting irregularities, may place Impath in violation of its debt covenants, thus bringing into question Impath's viability as a going concern.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus